Related Experiment Video
Updated: May 19, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Steroid Therapy in Community-Acquired Pneumonia: An Updated Systematic Review and Meta-Analysis.
Bijeta Keisham1, Sanchit Duhan2, Divyansh Bajaj3
1Department of Pulmonary Medicine, Christie Clinic, Champaign, IL, USA.
Corticosteroids significantly reduce mortality and hospitalization in severe community-acquired pneumonia (CAP). However, routine use in less severe CAP is not recommended due to lack of benefit and potential risks.
Area of Science:
- Pulmonology
- Critical Care Medicine
- Pharmacology
Background:
- Community-acquired pneumonia (CAP) presents a substantial global health challenge, especially in severe presentations.
- The efficacy of corticosteroids as an adjunctive therapy for CAP remains debated, necessitating further investigation.
Purpose of the Study:
- To evaluate the impact of corticosteroid therapy on mortality and morbidity in patients diagnosed with CAP.
- To synthesize evidence from randomized controlled trials (RCTs) to provide a definitive conclusion on corticosteroid use in CAP management.
Main Methods:
- A systematic review and meta-analysis of 20 RCTs comprising 5,866 adult CAP patients.
- Data synthesis using random-effects models to calculate risk ratios and mean differences with 95% confidence intervals.
- Assessment of statistical heterogeneity using the I² statistic to ensure robust findings.
Main Results:
- Corticosteroids did not significantly alter overall CAP mortality (RR 0.84; p=0.10).
- A significant reduction in mortality was observed in severe CAP cases (n=3,326; RR 0.73; p=0.01).
- Hospital and ICU length of stay were significantly reduced with corticosteroid use, without increasing mechanical ventilation, secondary infections, or gastrointestinal bleeding risks.
Conclusions:
- Corticosteroid administration improves outcomes in severe CAP, reducing mortality and hospitalization duration.
- The use of corticosteroids in less severe CAP is not supported by current evidence and should not be routinely implemented.
- Corticosteroids demonstrate a favorable safety profile in CAP patients, with no significant increase in adverse events.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
COPD: Management Using Bronchodilators and Corticosteroids
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Atypical Pneumonia